Dr. Eric Raabe of Johns Hopkins University is leading innovative research to tackle ATRT by addressing one of its root causes: faulty gene control that keeps tumor cells locked in an immature, aggressive state. This preclinical project tests a promising new drug called corin, which targets a key epigenetic protein complex that ATRT cells rely [...]
Embryonal tumor with multilayered rosettes (ETMR) is one of the rarest and most aggressive brain tumors affecting very young children, and relapse is heartbreakingly common. Dr. Johannes Gojo of the Medical University of Vienna is leading a forward-thinking research project to understand why ETMR tumors return and how resistant cancer cells manage to survive treatment. [...]
Atypical teratoid/rhabdoid tumors (ATRT) are rare, aggressive brain tumors that primarily affect very young children and have limited treatment options. Dr. Rajeev Vibhakar at the Children's Hospital of Colorado is leading research to investigate a promising new approach by targeting a critical protein—called CDK7—that ATRT tumor cells depend on to grow and survive. By blocking [...]
On Saturday, March 7, 2026, the Ty Louis Campbell Foundation will hold its 12th annual dinner party. Join us for an elegant evening of dining, dancing, casino games, and auction that is sure to transport you back to the gangster days of the 1940s and 1950s. This event brings together the TLC family of supporters to [...]
